OIL — Optiscan Imaging Share News
0.000.00%
Last trade - 00:00- AU$167.07m
- AU$154.06m
- AU$0.45m
Brief: Optiscan Imaging Lodges US FDA 510(K) Submission For Inform Digital Pathology Device
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australia's Optiscan Imaging gains on signing new cross-border research deal
Brief: Optiscan Imaging Lodges US FDA Dossier For Inspecta For Veterinary Market
Australia's Optiscan Imaging rises on deal with Australian Clinical Labs
Brief: Optiscan Imaging Enters Strategic Collaboration With Australian Clinical Labs
Brief: Optiscan Imaging Launches A$17.75M Entitlement Offer
Australia's Optiscan Imaging rises on collaboration with US-based firm
Brief: Optiscan Imaging Signs Agreement With Long Grove Pharmaceuticals
Australia's Optiscan Imaging gains on Mayo clinic collaboration progress
Brief: Optiscan Imaging Says Progressing Robotic Surgery Collaboration With Mayo Clinic
Brief: Optiscan Imaging Darius Ooi Promoted To Chief Financial Officer Role
Australia's Optiscan Imaging gains on ethical clearance for breast cancer study
Brief: Optiscan Imaging Got Ethical Clearance For Vivo In-Human Imaging For Breast Cancer
Australia's Optiscan Imaging surges on imaging device reveal
Brief: Optiscan Imaging Reveals Invue Imaging Device For Precision Surgery
Australia's Optiscan Imaging climbs to highest in 6 months after Mayo Clinic deal
Brief: Optiscan Imaging Entered Into Collaboration Through Know-How Agreement With Mayo Clinic
Australia's Optiscan Imaging slips on discounted capital raise